Johannes Gutenberg-Universitat Mainz

Organization

Mainz, DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Star polymers having a silyl coupling
- Patent number 12,037,438
- Issue date Jul 16, 2024
- Johannes Gutenberg-Universität Mainz
- Philipp von Tiedemann
- C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 11,858,988
- Issue date Jan 2, 2024
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 11,859,008
- Issue date Jan 2, 2024
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method and system for controlling a switch in the execution mode of...
- Patent number 11,789,621
- Issue date Oct 17, 2023
- Johannes Gutenberg-Universität Mainz
- André Brinkmann
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Methods and compositions for diagnosis and treatment of cancer
- Patent number 11,473,085
- Issue date Oct 18, 2022
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumo...
- Patent number 11,045,449
- Issue date Jun 29, 2021
- Johannes Gutenberg-Universität Mainz
- Markus Möhler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 10,919,974
- Issue date Feb 16, 2021
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy using CLDN6 target-directed antibodies in vivo
- Patent number 10,844,133
- Issue date Nov 24, 2020
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 10,745,477
- Issue date Aug 18, 2020
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 10,233,253
- Issue date Mar 19, 2019
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bifunctional chelating agents based on the 1,4-diazepine scaffold (...
- Patent number 10,130,722
- Issue date Nov 20, 2018
- Johannes Gutenberg-Universität Mainz
- Frank Rösch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies for treatment of cancer
- Patent number 10,125,196
- Issue date Nov 13, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 9,932,401
- Issue date Apr 3, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Identification of tumor-associated antigens for diagnosis and therapy
- Patent number 9,919,036
- Issue date Mar 20, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy using CLDN6 target-directed antibodies in vivo
- Patent number 9,902,778
- Issue date Feb 27, 2018
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for diagnosis and treatment of cancer
- Patent number 9,809,815
- Issue date Nov 7, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against claudin-18 for treatment of cancer
- Patent number 9,751,934
- Issue date Sep 5, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy using CLDN6 target-directed antibodies in vivo
- Patent number 9,718,886
- Issue date Aug 1, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for diagnosis and treatment of cancer
- Patent number 9,637,548
- Issue date May 2, 2017
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor vaccination involving a humoral immune response against self-...
- Patent number 9,617,321
- Issue date Apr 11, 2017
- Johannes Gutenberg-Universität Mainz
- Thorsten Klamp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against claudin-18 for treatment of cancer
- Patent number 9,499,609
- Issue date Nov 22, 2016
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 9,487,584
- Issue date Nov 8, 2016
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies for treatment of cancer
- Patent number 9,475,867
- Issue date Oct 25, 2016
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for improving the specific effector function of single-chain...
- Patent number 9,376,482
- Issue date Jun 28, 2016
- Johannes Gutenberg-Universität Mainz
- Ralf-Holger Voss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide derivatives for use...
- Patent number 9,364,459
- Issue date Jun 14, 2016
- Johannes Gutenberg-Universität Mainz
- Gerd Dannhardt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies for treatment of cancer
- Patent number 9,321,842
- Issue date Apr 26, 2016
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies for treatment of cancer
- Patent number 9,216,218
- Issue date Dec 22, 2015
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against claudin-18 for treatment of cancer
- Patent number 9,212,228
- Issue date Dec 15, 2015
- Ganymed Pharmaceuticals AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for therapy and diagnosis of cancer and ca...
- Patent number 9,061,007
- Issue date Jun 23, 2015
- Johannes Gutenberg-Universität Mainz
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for rational mutagenesis of α/βT-cell receptors and correspo...
- Patent number 9,062,127
- Issue date Jun 23, 2015
- Johannes Gutenberg-Universität Mainz
- Ralf-Holger Voss
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
RADIATION-DETECTED ZERO- TO ULTRALOW- FIELD NUCLEAR MAGNETIC RESONANCE
- Publication number 20250020605
- Publication date Jan 16, 2025
- Johannes Gutenberg-Universitat Mainz
- Dmitry BUDKER
- G01 - MEASURING TESTING
Information Patent Application
QUINAZOLINE-THIOHYDANTOIN FUSED HETEROCYCLES WHICH ARE SUITABLE FOR...
- Publication number 20240382490
- Publication date Nov 21, 2024
- Friedrich-Alexander-Universitat Erlangen-Nurnberg
- Svetlana TSOGOEVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLY(ETHYLENE GLYCOL) HAVING C1 TO C3-ALKYLOXYMETHYL SIDE CHAINS, B...
- Publication number 20240317934
- Publication date Sep 26, 2024
- Johannes Gutenberg-Universitat Mainz
- Holger FREY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INFORMATION PROCESSING APPARATUS
- Publication number 20240152793
- Publication date May 9, 2024
- Johannes Gutenberg-Universitat Mainz
- Peter VIRNAU
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20240101703
- Publication date Mar 28, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20240092896
- Publication date Mar 21, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20240084033
- Publication date Mar 14, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Microfluidic flow cell and system for analyzing or diagnosing biofi...
- Publication number 20240002764
- Publication date Jan 4, 2024
- Johannes Gutenberg-Universitat Mainz
- Ralf Heermann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Kits and methods for the enrichment and detection of RNA viruses of...
- Publication number 20230228752
- Publication date Jul 20, 2023
- Johannes Gutenberg-Universitat Mainz
- Bastian Hülsmann
- G01 - MEASURING TESTING
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
- Publication number 20230193261
- Publication date Jun 22, 2023
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITE RNA PARTICLES
- Publication number 20230099898
- Publication date Mar 30, 2023
- BIONTECH SE
- Heinrich HAAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD AND DEVICE FOR PROVIDING ANYONS, USE OF THE DEVICE
- Publication number 20220261678
- Publication date Aug 18, 2022
- Johannes Gutenberg-Universitat Mainz
- Jonas Nothhelfer
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
IN-VITRO METHOD FOR DETECTING AT LEAST ONE NUCLEIC ACID, WHICH IS L...
- Publication number 20220081709
- Publication date Mar 17, 2022
- Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V.
- Ralf HIMMELREICH
- G01 - MEASURING TESTING
Information Patent Application
STAR POLYMERS HAVING A SILYL COUPLING
- Publication number 20220041785
- Publication date Feb 10, 2022
- Johannes Gutenberg-Universitat Mainz
- Philipp VON TIEDEMANN
- C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information Patent Application
BONE SIALOPROTEIN FUNCTIONALIZED MATERIALS FOR DIRECTED BONE REGENE...
- Publication number 20220008620
- Publication date Jan 13, 2022
- IMMUNDIAGNOSTIK AG
- Franz Paul ARMBRUSTER
- B29 - WORKING OF PLASTICS WORKING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL
Information Patent Application
Process for the Oxidation of Carbon-Containing Organic Compounds wi...
- Publication number 20220010443
- Publication date Jan 13, 2022
- CONDIAS GMBH
- Siegfried WALDVOGEL
- C25 - ELECTROLYTIC OR ELECTROPHORETIC PROCESSES APPARATUS THEREFOR
Information Patent Application
ACRYLATE COPOLYMERS FOR GALENIC APPLICATIONS
- Publication number 20220002458
- Publication date Jan 6, 2022
- Johannes Gutenberg-Universitat Mainz
- Holger FREY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA Particles Comprising Polysarcosine
- Publication number 20220001025
- Publication date Jan 6, 2022
- Johannes Gutenberg-Universitat Mainz
- Matthias Barz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20210179730
- Publication date Jun 17, 2021
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD AND SYSTEM FOR CONTROLLING A SWITCH IN THE EXECUTION MODE OF...
- Publication number 20210165588
- Publication date Jun 3, 2021
- Johannes Gutenberg-Universitat Mainz
- André BRINKMANN
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20210079113
- Publication date Mar 18, 2021
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYETHER-BASED BLOCK COPOLYMERS HAVING HYDROPHOBIC DOMAINS
- Publication number 20200407479
- Publication date Dec 31, 2020
- Johannes Gutenberg-Universitat Mainz
- Patrick VERKOYEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20200339677
- Publication date Oct 29, 2020
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-(5-Fluoroindolyl)-4-arylmaleimide Compounds and their Use in Tumo...
- Publication number 20200253930
- Publication date Aug 13, 2020
- Johannes Gutenberg-Universitat Mainz
- Markus Möhler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL AGENT FOR IRON CHELATING
- Publication number 20190359769
- Publication date Nov 28, 2019
- Johannes Gutenberg-Universitat Mainz
- Holger FREY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
- Publication number 20190169614
- Publication date Jun 6, 2019
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20190010244
- Publication date Jan 10, 2019
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20180162938
- Publication date Jun 14, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20180142033
- Publication date May 24, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
- Publication number 20180127489
- Publication date May 10, 2018
- GANYMED PHARMACEUTICALS AG
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Johannes Gutenberg-Universitat Mainz

Organization

Patents Grantslast 30 patents

Star polymers having a silyl coupling

Antibodies specific for claudin 6 (CLDN6)

Antibodies for treatment of cancer expressing claudin 6

Method and system for controlling a switch in the execution mode of...

Methods and compositions for diagnosis and treatment of cancer

3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumo...

Antibodies for treatment of cancer expressing claudin 6

Cancer therapy using CLDN6 target-directed antibodies in vivo

Antibodies specific for claudin 6 (CLDN6)

Antibodies for treatment of cancer expressing claudin 6

Bifunctional chelating agents based on the 1,4-diazepine scaffold (...

Monoclonal antibodies for treatment of cancer

Antibodies specific for claudin 6 (CLDN6)

Identification of tumor-associated antigens for diagnosis and therapy

Cancer therapy using CLDN6 target-directed antibodies in vivo

Methods and compositions for diagnosis and treatment of cancer

Monoclonal antibodies against claudin-18 for treatment of cancer

Cancer therapy using CLDN6 target-directed antibodies in vivo

Methods and compositions for diagnosis and treatment of cancer

Tumor vaccination involving a humoral immune response against self-...

Monoclonal antibodies against claudin-18 for treatment of cancer

Antibodies specific for claudin 6 (CLDN6)

Monoclonal antibodies for treatment of cancer

Method for improving the specific effector function of single-chain...

3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide derivatives for use...

Antibodies for treatment of cancer

Monoclonal antibodies for treatment of cancer

Monoclonal antibodies against claudin-18 for treatment of cancer

Compositions and methods for therapy and diagnosis of cancer and ca...

Method for rational mutagenesis of α/βT-cell receptors and correspo...

Patents Applicationslast 30 patents

RADIATION-DETECTED ZERO- TO ULTRALOW- FIELD NUCLEAR MAGNETIC RESONANCE

QUINAZOLINE-THIOHYDANTOIN FUSED HETEROCYCLES WHICH ARE SUITABLE FOR...

POLY(ETHYLENE GLYCOL) HAVING C1 TO C3-ALKYLOXYMETHYL SIDE CHAINS, B...

INFORMATION PROCESSING APPARATUS

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

Microfluidic flow cell and system for analyzing or diagnosing biofi...

Kits and methods for the enrichment and detection of RNA viruses of...

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

COMPOSITE RNA PARTICLES

METHOD AND DEVICE FOR PROVIDING ANYONS, USE OF THE DEVICE

IN-VITRO METHOD FOR DETECTING AT LEAST ONE NUCLEIC ACID, WHICH IS L...

STAR POLYMERS HAVING A SILYL COUPLING

BONE SIALOPROTEIN FUNCTIONALIZED MATERIALS FOR DIRECTED BONE REGENE...

Process for the Oxidation of Carbon-Containing Organic Compounds wi...

ACRYLATE COPOLYMERS FOR GALENIC APPLICATIONS

RNA Particles Comprising Polysarcosine

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

METHOD AND SYSTEM FOR CONTROLLING A SWITCH IN THE EXECUTION MODE OF...

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

POLYETHER-BASED BLOCK COPOLYMERS HAVING HYDROPHOBIC DOMAINS

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

3-(5-Fluoroindolyl)-4-arylmaleimide Compounds and their Use in Tumo...

PHARMACEUTICAL AGENT FOR IRON CHELATING

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER